DESCRIPTIVE EPIDEMIOLOGY OF OVARIAN-CANCER IN EUROPE

被引:22
作者
LAVECCHIA, C
LEVI, F
LUCCHINI, F
NEGRI, E
FRANCESCHI, S
机构
[1] UNIV LAUSANNE,INST MED SOCIALE & PREVENT,BUGNON 17,CH-1005 LAUSANNE,SWITZERLAND
[2] MARIO NEGRI INST PHARMACOL RES,I-20157 MILAN,ITALY
[3] CHU VAUDOIS,INST UNIV MED SOCIALE & PREVENT,CH-1011 LAUSANNE,SWITZERLAND
[4] CTR RIFERIMENTO ONCOL,EPIDEMIOL SERV,I-33081 AVIANO,ITALY
关键词
D O I
10.1016/0090-8258(92)90257-J
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Trends in ovarian cancer mortality over the period 1955-1989 were analyzed for 25 European countries (excluding the Soviet Union and a few small countries) on the basis of the official death certification data from the World Health Organization database. The overall variation in age-standardized ovarian cancer mortality at all ages declined appreciably, from over 17-fold during the period 1955-1959 (i.e., between 10.5 100,000 in Denmark and 0.6 100,000 in Spain, world standard) to 3.4-fold (i.e., between 9.9 100,000 in Denmark and 2.9 100,000 in Spain) in the late 1980s. When a comparison was made between the late 1950s and the 1980s, ovarian cancer mortality increased in most European countries, except Denmark, Sweden, and Switzerland, where certified mortality was already elevated in the late 1950s, although also in these countries the peak rate around or over 10 100,000 was reached during the 1960s. However, when the changes over the last decade were considered, ovarian cancer mortality trends were downward in all Nordic countries, Germany, Switzerland, Austria, and Czechoslovakia. Mortality was rising somewhat, though to a smaller extent, in Ireland, Britain, and Southern Europe. Trends were more favorable in middle-aged women (35 to 64 years), and, to an even greater extent, in young women (aged 20 to 44), among whom substantial declines, particularly over the last decade, were observed in most European countries, approaching 50% in Britain and Scandinavia. These trends are discussed in terms of changes in risk factor exposure (i.e., trends in average parity and oral contraceptive use), diagnostic and therapeutic improvements, ovariectomy, and changes in case ascertainment and certification. © 1992.
引用
收藏
页码:208 / 215
页数:8
相关论文
共 27 条
[1]  
[Anonymous], 1967, INT CLASSIFICATION D
[2]   IMPROVED PROGNOSIS OF OVARIAN-CANCER IN THE NETHERLANDS DURING THE PERIOD 1975-1985 - A REGISTRY-BASED STUDY [J].
BALVERTLOCHT, HR ;
COEBERGH, JWW ;
HOP, WCJ ;
BROLMANN, HAM ;
CROMMELIN, M ;
VANWIJCK, DJAM ;
VERHAGENTEULINGS, MTCIJ .
GYNECOLOGIC ONCOLOGY, 1991, 42 (01) :3-8
[3]  
BONE MR, 1980, HLTH TRENDS, V12, P87
[4]   THE CAUSES OF CANCER - QUANTITATIVE ESTIMATES OF AVOIDABLE RISKS OF CANCER IN THE UNITED-STATES TODAY [J].
DOLL, R ;
PETO, R .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1981, 66 (06) :1191-+
[5]  
DOLL R, 1990, EUR J CANCER, V26, P500
[6]  
Doll R, 1982, IARC SCI PUBL, V42, p[IV, 671]
[7]  
DOSSANTOS SI, 1991, BRIT J CANCER, V63, P814
[8]   POOLED ANALYSIS OF 3 EUROPEAN CASE-CONTROL STUDIES OF EPITHELIAL OVARIAN-CANCER .3. ORAL-CONTRACEPTIVE USE [J].
FRANCESCHI, S ;
PARAZZINI, F ;
NEGRI, E ;
BOOTH, M ;
LAVECCHIA, C ;
BERAL, V ;
TZONOU, A ;
TRICHOPOULOS, D .
INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (01) :61-65
[9]  
JENSEN OM, 1990, EUR J CANCER, V26, P1167
[10]  
LAVECCHIA C, 1991, ANTI-CANCER DRUG, V2, P215